Explore our ACCC 2020 Impact Report, the Oncology Issues, Vol.36 N.5, and our video podcast, CANCER BUZZ TV.
 

Share

    


In This Section

Home / Learn / President's Theme 2021-2022 / President's Theme 2020-2021

President's Theme 2020-2021

Randall-Oyer-200x200

Randall A. Oyer, MD, was named the Association of Community Cancer Centers (ACCC) President for 2020-2021 at the ACCC 46th Annual Meeting & Cancer Center Business Summit held March 4-6 in Washington, D.C.

ACCC invites each president to select a theme for their year in office that addresses a timely issue in cancer care through the creation of programs and resources. Dr. Oyer announced that the theme of his presidency will be “Community Oncology Can Close the Gap in Cancer Research.”

“Over the past year ACCC has heard from our members that there are gaps in community research,” said Dr. Oyer. Respondents to ACCC’s “2019 Trending Now in Cancer Care Survey” identified their top three challenges to offering patients with cancer clinical trials as staff resources and training (53%), program infrastructure (50%), and lack of patient understanding of the clinical trials process (46%). Citing these survey findings, Dr. Oyer remarked: “We have a serious imbalance in our clinical trials work. Our patients are in the community, yet the trials are at academic medical centers. And I believe that ACCC is uniquely situated to close this gap.”

Among the plans to achieve this goal outlined by Dr. Oyer were the following:

  • Creating a multidisciplinary taskforce to identify staff/program/patient education resources needed to accelerate implementation of clinical trials in ACCC member practices and programs
  • Bringing together experts at the 2020 ACCC Institute for the Future of Oncology forum to share best practices and learn more about challenges and barriers to clinical trials adoption
  • Developing a series of articles, blogs, and podcasts on effective practices in clinical trials accrual and management.

“We would like to improve our care and access for traditionally underserved communities. We would like to increase sensitivity, awareness, and understanding of the needs specific to geriatric oncology. And we would like to bring precision medicine into the community by understanding how to use the new precision diagnostics and radiology techniques to make sure that our patients have access to these services.”

The resources and tools that will be developed in conjunction with Dr. Oyer’s President’s Theme will be posted to this webpage as they are available.

Featured Program

ACCC Community Oncology Research Institute

The Association of Community Cancer Centers (ACCC) has established the ACCC Community Oncology Research Institute (ACORI) to build on its existing mission to close the gap in cancer research through optimal oncology partnerships.
Learn More

 

Featured Program


ASCO President Lori J. Pierce, MD, discusses the ASCO-ACCC Collaboration during her #ASCO21 President's Address.

ASCO-ACCC Initiative to Increase Racial and Ethnic Diversity in Clinical Trials

ACCC and ASCO are collaborating to increase cancer clinical trial participation among patients from underrepresented racial and ethnic groups. The two organizations are currently recruiting 40 oncology research programs to be part of a pilot program testing a site assessment tool and/or an implicit bias training program.
Learn More

 

From Oncology Issues

  •  Community Oncology Can Close the Gap in Cancer Research
    Amanda Patton, MA
    One of the ways in which community oncology is helping to close gaps in cancer research is through participation in the National Cancer Institute Community Oncology Research Program clinical trials. The Lahey Health Cancer Institute, a part of the Beth Israel Lahey Health System, continues to expand access to clinical trials and, in particular, the NCI National Clinical Trials Network into the community by partnering with affiliated community hospitals.
  •  Trending Now in Cancer Care
    Alexandria Howson, PhD
    Rather than fielding its annual Trending Now in Cancer Care survey while cancer programs were experiencing unprecedented challenges due to the extended public health emergency, ACCC chose to facilitate conversations with its members to capture the lived experiences of the most pertinent issues impacting oncology practice and care delivery.
  •  Community Oncology Can Close the Gap in Cancer Research
    Amanda Patton, MA
    This is the story of how a large independent practice in northwest Arkansas has nurtured its research program over several decades and is now able to offer patients access to phase I, II, and III trials close to home and their families.

COVID-19 & Cancer Patient Registry: Your Voice Matters


May 12, 2020
Randall Oyer 385x247 (1)

As experience with COVID-19 is collected, we are learning that people with cancer are more likely to experience worse outcomes. Patients with cancer are also significantly impacted by disruptions in the healthcare system that may lead to delays or changes in treatment plans. It is imperative that we examine and understand much more about the impact of this pandemic on cancer patients and survivors so that we can effectively and rapidly make improvements to care delivery.

On behalf of the Association of Community Cancer Centers (ACCC) and the American Society of Clinical Oncology (ASCO), I strongly encourage you to contribute to the new ASCO Survey on COVID-19 in Oncology Registry (ASCO Registry). Your help in developing a large data set is critical for researchers who are studying the important questions to which we need confirmed answers.

This critical cancer patient registry collects information about patterns of symptoms and severity of COVID-19 infection, how COVID-19 influences the delivery of cancer care, and how patient cancer and COVID-19 outcomes are affected.

As part of the 2020-2021 ACCC President’s Theme, Community Oncology Can Close the Gap in Cancer Research, ACCC is exploring the impact of COVID-19 on all facets of cancer care, including the administration of—and patient access to—clinical trials. COVID-19 poses a particularly significant challenge for oncology clinical trials, as investigational approaches are often considered standard of care for many disease types.

Once sufficient patient data have been received and analyzed, ASCO will deliver periodic reports on key insights, including characteristics of patients with cancer most impacted by COVID-19, estimates of disease severity, treatment modifications or delays, implementation of telemedicine in the cancer treatment setting, and clinical outcomes among patients related to both COVID-19 and cancer.

The registry is open to all oncology programs, including physician-owned, academic, and hospital/health system-owned practices, and hospitals in the United States. You can learn more about the ASCO Registry by clicking here.

Please also be aware that CMS has announced that ASCO’s Survey on COVID-19 in Oncology Registry is an acceptable clinical trial registry for the MIPS COVID-19 Clinical Trials Improvement Activity.

Thank you in advance for your time and consideration of this critical research initiative. Please join us in helping to improve cancer care.

Sincerely,

 

Clinical Trial Resources

  • Virtual Navigation to Clinical Trials
    Jan 4, 2019

    In the current oncology clinical trials landscape, many barriers remain to clinical trial enrollment that affect both the oncologist and the patient. Among these are trial locations, strict eligibility requirements, insufficient resources to support appropriate clinical trial education and screening, as well as patient and provider attitudes about trials.

  • IO Trials Are Accruing: Where Are the Patients?
    Sep 10, 2018

    Research nurse Joannne Riemer, RN, BSN,  started her position at Johns Hopkins Medical Institution in 2010. Within six months, she was working with checkpoint inhibitors. From her vantage point in clinical trials research, she discusses the many changes in IO clinical trials patient selection over the last eight years. 

Podcast

COVID-19 Resources

HHS-60x60combatCOVID.hhs.gov provides important information and links to access the most current treatment guidelines and inpatient and outpatient clinical trials.

Live and On-Demand Webinars